Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.68 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.68 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.58 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.51 |
| ▸ | ABAT | P80404 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29878741 | 1.00 | CRHBP (0.68) | CRHBPCRHR2ABCC1ABCB1MAPT | |
| SCHEMBL28537073 | 0.98 | CRHBP (0.66) | CRHBPCRHR2ABCC1ABCB1MAPT | |
| SCHEMBL9318576 | 0.93 | CRHBP (0.65) | CRHBPCRHR2ABCC1ABCB1MAPT | |
| Benzoic Acid SCHEMBL1897368 | 0.91 | ABCC1 (0.57) | CRHBPCRHR2ABCC1ABCB1MAPT | |
| SCHEMBL4368126 | 0.90 | MAPT (0.67) | CRHBPCRHR2MAPTALDH1A1MAPK1 | |
| SCHEMBL29484215 | 0.90 | MAPT (0.67) | CRHBPCRHR2MAPTALDH1A1MAPK1 | |
| SCHEMBL9306308 | 0.86 | MAPT (0.62) | CRHBPCRHR2MAPTALDH1A1MAPK1 | |
| SCHEMBL29878908 | 0.85 | CRHBP (0.68) | CRHBPCRHR2ABCC1ABCB1MAPT | |
| SCHEMBL5595131 | 0.85 | CRHBP (0.68) | CRHBPCRHR2ABCC1ABCB1MAPT | |
| SCHEMBL4340852 | 0.84 | ERN1 (0.61) | CRHBPCRHR2ABCC1ABCB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820174-A | Synthesis method of bifenazate | 山东华阳农药化工集团有限公司 | 2024-04-05 | — | — | CN | claimed |
| EP-1274673-B1 | METHOD FOR PRODUCING 4-HYDROXY-3-NITROBIPHENYL | SALTIGO GMBH (DE) | 2006-10-11 | — | — | EP | claimed |
| WO-2005014534-A1 | ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | TRANSTECH PHARMA, INC. (US) | 2005-02-17 | — | — | WO | claimed |
| US-6610893-B2 | Selectively nitrating 4-hydroxybiphenyl in the position adjacent to the phenolic hydroxyl group | BAYER AKTIENGESELLSCHAFT (DE) | 2003-08-26 | — | — | US | claimed |
| US-20030055294-A1 | Method for producing 4-hydroxy-3-nitrobiphenyl | LANXESS DEUTSCHLAND GMBH (DE) | 2003-03-20 | — | — | US | claimed |
| EP-1274673-A1 | METHOD FOR PRODUCING 4-HYDROXY-3-NITROBIPHENYL | Bayer Aktiengesellschaft (DE) | 2003-01-15 | — | — | EP | claimed |
| WO-2001077061-A1 | METHOD FOR PRODUCING 4-HYDROXY-3-NITROBIPHENYL | BAYER AKTIENGESELLSCHAFT (DE) | 2001-10-18 | — | — | WO | claimed |
| CN-117623947-B | Synthesis method of bifenazate intermediate | 绍兴上虞新银邦生化有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-118388379-A | Organic total synthesis method of nimesulide derivative | 大连理工大学 | 2024-07-26 | — | — | CN | disclosed |
| CN-117820174-A | Synthesis method of bifenazate | 山东华阳农药化工集团有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117623947-A | Synthesis method of bifenazate intermediate | 绍兴上虞新银邦生化有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-117229154-A | Preparation method of bifenazate intermediate | 帕潘纳(北京)科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-115124485-B | Sulfoxide-containing benzoxazole derivative, and preparation method and application thereof | 中国医学科学院药物研究所 | 2023-12-15 | — | — | CN | disclosed |
| US-5344980-A | Process for the preparation of 1,3,5-tris(4'-hydroxyaryl)benzene | HOECHST CELANESE CORP. (US) | 1994-09-06 | — | — | US | disclosed |
| EP-0576603-A1 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA, CONTAINING A 5 ALPHA-REDUCTASE INHIBITOR AND AN ANTIANDROGEN | MERCK & CO. INC. (US) | 1994-01-05 | — | — | EP | disclosed |
| EP-0526093-A1 | New non-steroidal agents as 5-alpha reductase inhibitors | MERCK & CO. INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| EP-0525885-A1 | New sulphur containing nonsteroidal drugs as 5-alpha reductase inhibitors | MERCK & CO. INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1992018132-A1 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA COMTAINING A 5 ALPHA-REDUCTASE INHIBITOR | MERCK & CO., INC. (US) | 1992-10-29 | — | — | WO | disclosed |
| WO-1992016213-A1 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA, CONTAINING A 5 ALPHA-REDUCTASE INHIBITOR AND AN ANTIANDROGEN | MERCK & CO., INC. (US) | 1992-10-01 | — | — | WO | disclosed |
| WO-1992016233-A1 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN | MERCK & CO., INC. (US) | 1992-10-01 | — | — | WO | disclosed |